Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma

Acta Oncol. 2011 Apr;50(3):462-5. doi: 10.3109/0284186X.2010.491088. Epub 2010 Aug 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Carcinoma, Ductal, Breast / drug therapy*
  • Carcinoma, Ductal, Breast / pathology
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Dose-Response Relationship, Drug
  • Fatal Outcome
  • Female
  • Gemcitabine
  • Humans
  • Middle Aged
  • Neoplasm Metastasis
  • Palliative Care / methods
  • Salvage Therapy
  • Thrombotic Microangiopathies / chemically induced*
  • Thrombotic Microangiopathies / diagnosis

Substances

  • Antineoplastic Agents
  • Deoxycytidine
  • Gemcitabine